FIELD: analytical chemistry.
SUBSTANCE: method of the simultaneous quantitative determination of lisinopril, indapamide, valsartan, amlodipine, and metoprolol in blood plasma including the use of the HPLC-MS/MS method, is disclosed. Sample preparation is carried out with the precipitation of proteins by mixing 200 μl of a blood plasma sample with 600 μl of acetonitrile, followed by shaking for 10 minutes and further centrifugation at 19,000g for 10 minutes at a temperature of + 4°C, followed by injection of 5 μl of the sample using an autosampler and separation on a UCT Selectra C18 4.6 mm column×100 mm, 3um, 100A with precolumn Selectra C18 Guard Cartridges SLC-18GDC46-3UM at a temperature of 35°C, in a gradient elution mode in the ratio of 0.1% formic acid solution/acetonitrile: 0 min — 80%/20%, 0.1 min — 45%/55%, 5 min — 10%/90%, 10 min — 80%/20%, with a flow rate of 300 µl/min and detection in positive mode electrospray ionization, electrospray voltage 4,000 V, shell gas 50 arb, auxiliary gas 10 arb, purge gas 1 arb, evaporator temperature 350°C, ion transport tube temperature — 300°C, using MRM mode with argon supply pressure of 2 mTorr.
EFFECT: invention provides a sensitive, selective, accurate and precision method for the quantitative determination of the specified mixture of substances in blood plasma.
6 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR QUANTITATIVE DETERMINATION OF MALONDIALDEHYDE BY HPLC-MS/MS | 2022 |
|
RU2789058C1 |
METHOD OF QUANTIFICATION OF AMANTADINE IN BLOOD PLASMA | 2017 |
|
RU2650968C1 |
METHOD OF TREATING CARDIOVASCULAR DISEASES | 2012 |
|
RU2570752C2 |
DETERMINING HGH FOR USE IN PREVENTING A SEVERE ADVERSE CARDIOVASCULAR EVENT OR CARDIOVASCULAR DISEASE IN AN INDIVIDUAL | 2015 |
|
RU2740254C2 |
METHOD FOR DETERMINATION OF METHYLDOPE CONCENTRATION IN HUMAN BLOOD PLASMA | 2016 |
|
RU2642593C1 |
METHOD FOR DETERMINATION OF MYCOPHENOLIC ACID CONCENTRATION IN HUMAN BLOOD PLASMA | 2017 |
|
RU2642288C1 |
PHARMACEUTICAL COMBINATIONS OF ANGIOTENSIN RECEPTOR ANTAGONIST AND NEP INHIBITOR | 2006 |
|
RU2503668C2 |
PHARMACEUTICAL COMBINATIONS OF ANGIOTENSINE RECEPTOR ANTAGONIST AND NEP INHIBITOR | 2006 |
|
RU2459809C2 |
MEDICINAL AGENT FOR TREATMENT OF HYPERTENSION OR HIGH BLOOD PRESSURE | 2010 |
|
RU2539382C2 |
METHOD OF DETERMINING CONCENTRATION OF WARFARIN ALCOHOL IN BLOOD PLASMA | 2012 |
|
RU2486521C1 |
Authors
Dates
2023-09-21—Published
2022-09-23—Filed